[{"address1": "369 South San Antonio Road", "city": "Los Altos", "state": "CA", "zip": "94022", "country": "United States", "phone": "650 200 0412", "website": "https://www.altoneuroscience.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Alto Neuroscience, Inc. operates as a clinical-stage biopharmaceutical company in the United States. Its product pipeline comprising ALTO-100, which is in phase 2b clinical trial for the treatment of patients with major depressive disorder (MDD); and which is in phase 2a clinical trial for the treatment of post-traumatic stress disorder. The company develops ALTO-300, a small molecule melatonergic agonist and serotonergic antagonist with antidepressant properties which is in phase 2b clinical trial to treat patients with MDD; ALTO-101, a novel small molecule phosphodiesterase 4 inhibitor which is in phase 1 clinical trial for the treatment of cognitive impairment associated with schizophrenia; ALTO-203, a novel small-molecule histamine H3 receptor inverse agonist which is in phase 1 clinical trial to treat patients with MDD and higher levels of anhedonia; and ALTO-202, an investigational orally bioavailable antagonist of the GluN2B subunit of the NMDA receptor which is in phase 1 clinical trial for the treatment of MDD. In addition, it develops novel pharmacodynamically synergistic combination and biomarker platform that collects patient-specific data to identify biomarker-characterized patient. The company was incorporated in 2019 and is headquartered in Los Altos, California.", "fullTimeEmployees": 88, "companyOfficers": [{"maxAge": 1, "name": "Dr. Amit  Etkin M.D., Ph.D.", "age": 47, "title": "Founder, Chairman of the Board, CEO & President", "yearBorn": 1977, "fiscalYear": 2023, "totalPay": 705653, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Nicholas C. Smith", "age": 35, "title": "CFO & Secretary", "yearBorn": 1989, "fiscalYear": 2023, "totalPay": 624125, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Adam  Savitz M.D., Ph.D.", "age": 58, "title": "Chief Medical Officer", "yearBorn": 1966, "fiscalYear": 2023, "totalPay": 579569, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Erin R. McQuade J.D.", "age": 49, "title": "General Counsel & Chief Administrative Officer", "yearBorn": 1975, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Jessica  Powell", "age": 49, "title": "Chief Development Officer", "yearBorn": 1975, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 3.12, "open": 3.18, "dayLow": 3.07, "dayHigh": 3.22, "regularMarketPreviousClose": 3.12, "regularMarketOpen": 3.18, "regularMarketDayLow": 3.07, "regularMarketDayHigh": 3.22, "payoutRatio": 0.0, "forwardPE": -1.1149826, "volume": 119473, "regularMarketVolume": 119473, "averageVolume": 261249, "averageVolume10days": 268840, "averageDailyVolume10Day": 268840, "bid": 3.19, "ask": 3.2, "bidSize": 8, "askSize": 10, "marketCap": 86304640, "fiftyTwoWeekLow": 3.0, "fiftyTwoWeekHigh": 18.35, "fiftyDayAverage": 4.0394, "twoHundredDayAverage": 8.9759, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -82066072, "profitMargins": 0.0, "floatShares": 19401530, "sharesOutstanding": 26970200, "sharesShort": 4048269, "sharesShortPriorMonth": 3973621, "sharesShortPreviousMonthDate": 1735603200, "dateShortInterest": 1738281600, "sharesPercentSharesOut": 0.15010001, "heldPercentInsiders": 0.07509, "heldPercentInstitutions": 0.89709, "shortRatio": 18.14, "shortPercentOfFloat": 0.1906, "impliedSharesOutstanding": 26970200, "bookValue": 6.12, "priceToBook": 0.52287585, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1727654400, "netIncomeToCommon": -57447000, "trailingEps": -2.38, "forwardEps": -2.87, "enterpriseToEbitda": 1.304, "52WeekChange": -0.77259475, "SandP52WeekChange": 0.2021538, "quoteType": "EQUITY", "currentPrice": 3.2, "targetHighPrice": 18.0, "targetLowPrice": 4.0, "targetMeanPrice": 12.72333, "targetMedianPrice": 13.5, "recommendationMean": 1.28571, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 6, "totalCash": 181700992, "totalCashPerShare": 6.737, "ebitda": -62934000, "totalDebt": 15488000, "quickRatio": 12.965, "currentRatio": 13.095, "debtToEquity": 9.384, "returnOnAssets": -0.32356, "returnOnEquity": -0.56723, "freeCashflow": -32367000, "operatingCashflow": -45927000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "ANRO", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "marketState": "POST", "shortName": "Alto Neuroscience, Inc.", "corporateActions": [], "postMarketTime": 1740171623, "regularMarketChangePercent": 2.564108, "regularMarketPrice": 3.2, "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "regularMarketTime": 1740171595, "exchange": "NYQ", "messageBoardId": "finmb_1675972978", "fiftyDayAverageChangePercent": -0.20780315, "twoHundredDayAverageChange": -5.7759, "twoHundredDayAverageChangePercent": -0.6434898, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.3 - Strong Buy", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1706884200000, "postMarketChangePercent": -0.3124997, "postMarketPrice": 3.19, "postMarketChange": -0.00999999, "regularMarketChange": 0.08000016, "regularMarketDayRange": "3.07 - 3.22", "fullExchangeName": "NYSE", "averageDailyVolume3Month": 261249, "fiftyTwoWeekLowChange": 0.20000005, "fiftyTwoWeekLowChangePercent": 0.066666685, "fiftyTwoWeekRange": "3.0 - 18.35", "fiftyTwoWeekHighChange": -15.150001, "fiftyTwoWeekHighChangePercent": -0.8256131, "fiftyTwoWeekChangePercent": -77.259476, "epsTrailingTwelveMonths": -2.38, "epsForward": -2.87, "fiftyDayAverageChange": -0.83940005, "displayName": "Alto Neuroscience", "trailingPegRatio": null, "__fetch_time": "2025-02-21"}]